Kootenai Health

"""""""IODOFORM PACKING STRIP 1/2"""""""" X 5 YD CURAD"""""""

"""""""POUCH OSTOMY 12"""""""" DRAINABLE 18193"""""""

1925

2019-NCOV CORONAVIRUS, SARS-COV-2/2019-NCOV (COVID-19), ANY TECHNIQUE, MULTIPLE TYPES OR SUBTYPES (INCLUDES ALL TARGETS), NON-CDC

29125 APPLICATION OF SHORT ARM SPLINT (FOREARM TO HAND); STA

29130 ed proc application of finger splint static

3-DIMENSIONAL RADIOTHERAPY PLAN, INCLUDING DOSE-VOLUME HISTOGRAMS

36000 ed proc introduction of needle or intracathe

37799 ed proc vascular surgery unlisted proc

3D RENDERING WITH INTERPRETATION AND REPORTING OF COMPUTED TOMOGRAPHY, MAGNETIC RESONANCE IMAGING, ULTRASOUND, OR OTHER TOMOGRAPHIC MODALITY WITH IMAGE POSTPROCESSING UNDER CONCURRENT SUPERVISION; NOT REQUIRING IMAGE POSTPROCESSING ON AN INDEPENDENT WORKSTATION

3D RENDERING WITH INTERPRETATION AND REPORTING OF COMPUTED TOMOGRAPHY, MAGNETIC RESONANCE IMAGING, ULTRASOUND, OR OTHER TOMOGRAPHIC MODALITY WITH IMAGE POSTPROCESSING UNDER CONCURRENT SUPERVISION; REQUIRING IMAGE POSTPROCESSING ON AN INDEPENDENT WORKSTATION

45339 sigmoidoscopy w/ aplation of tumor/polyp

5% DEXTROSE IN LACTATED RINGERS INFUSION, UP TO 1000 CC

58160-0890-52 - influenza virus vaccine, inactivated preservative-free quadrivalent Sus [MEMO]

6.0MM TI LOCKING SCREW

ABDOMINAL PARACENTESIS (DIAGNOSTIC OR THERAPEUTIC); WITH IMAGING GUIDANCE

ABDOMINAL PARACENTESIS (DIAGNOSTIC OR THERAPEUTIC); WITHOUT IMAGING GUIDANCE

ABL1 (ABL PROTO-ONCOGENE 1, NON-RECEPTOR TYROSINE KINASE) (EG, ACQUIRED IMATINIB TYROSINE KINASE INHIBITOR RESISTANCE), GENE ANALYSIS, VARIANTS IN THE KINASE DOMAIN

ABLATION THERAPY FOR REDUCTION OR ERADICATION OF 1 OR MORE BONE TUMORS (EG, METASTASIS) INCLUDING ADJACENT SOFT TISSUE WHEN INVOLVED BY TUMOR EXTENSION, PERCUTANEOUS, INCLUDING IMAGING GUIDANCE WHEN PERFORMED; RADIOFREQUENCY

ABLATION, 1 OR MORE LIVER TUMOR(S), PERCUTANEOUS, RADIOFREQUENCY

ABLATION, 1 OR MORE RENAL TUMOR(S), PERCUTANEOUS, UNILATERAL, RADIOFREQUENCY

ABLATION, RENAL TUMOR(S), UNILATERAL, PERCUTANEOUS, CRYOTHERAPY

ABLATION, SOFT TISSUE OF INFERIOR TURBINATES, UNILATERAL OR BILATERAL, ANY METHOD (EG, ELECTROCAUTERY, RADIOFREQUENCY ABLATION, OR TISSUE VOLUME REDUCTION); SUPERFICIAL

ABOBOTULINUMTOXINA

ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTERO

ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY

ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY

ABORTION WITHOUT D&C

ACETAZOLAMIDE LESS THAN500MG 500MG 5MLSNIJ

ACETYLCHOLINE RECEPTOR (ACHR); BINDING ANTIBODY

ACETYLCHOLINE RECEPTOR (ACHR); MODULATING ANTIBODY

ACETYLCYSTEINE 200 MG/ML (20 %) INTRAVENOUS SOLUTION [35100]

ACNE SURGERY (EG, MARSUPIALIZATION, OPENING OR REMOVAL OF MULTIPLE MILIA, COMEDONES, CYSTS, PUSTULES)

ACTH STIMULATION PANEL; FOR ADRENAL INSUFFICIENCY THIS PANEL MUST INCLUDE THE FOLLOWING: CORTISOL (82533 X 2)

ACTIN (SMOOTH MUSCLE) ANTIBODY (ASMA), EACH

ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNC

ACUTE AND SUBACUTE ENDOCARDITIS

ACUTE AND SUBACUTE ENDOCARDITIS

ACUTE AND SUBACUTE ENDOCARDITIS WITH CC

ACUTE AND SUBACUTE ENDOCARDITIS WITH MCC

ACUTE HEPATITIS PANEL THIS PANEL MUST INCLUDE THE FOLLOWING: HEPATITIS A ANTIBODY (HAAB), IGM ANTIBODY (86709) HEPATITIS B CORE ANTIBODY (HBCAB), IGM ANTIBODY (86705) HEPATITIS B SURFACE ANTIGEN (HBSAG) (87340) HEPATITIS C ANTIBODY (86803)

ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES AGE >17 WITH CC

ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES AGE >17 WITH MCC

ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH

ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH

ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC

ACUTE MYOCARDIAL INFARCTION, EXPIRED WITH CC

ACUTE MYOCARDIAL INFARCTION, EXPIRED WITH MCC

ACYCLOVIR SODIUM 50 MG/ML INTRAVENOUS SOLUTION [4235]

ADALIMUMAB CONC & ABS (LCP 503890)